Table 3. Distribution of IGF-I, IGFBP-1, IGFBP-3, and insulin among endometrial cancer cases and control women.
|
Cases (n=288) |
Controls (n=392) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| n | Mean (s.d.) | Median | Range | n | Mean (s.d.) | Median | Range | P-value* | |
| IGF-I (ng ml−1) | 274 | 115.5 (61.3) | 103.0 | 22–403 | 313 | 110.6 (50.4) | 101.0 | 18–373 | 0.8422 |
| IGFBP-1 (ng ml−1) | 274 | 32.2 (20.4) | 28.2 | 1.9–101 | 313 | 28.9 (19.1) | 24.6 | 2.7–112 | 0.0430 |
| IGFBP-3 (ng ml−1) | 257 | 6.1 (2.3) | 5.7 | 0.1–12.4 | 286 | 6.1 (2.3) | 6.0 | 0.9–12.4 | 0.6192 |
| Insulin (ng ml−1) | 260 | 14.0 (13.9) | 10.0 | 2.0–119.0 | 296 | 15.3 (16.7) | 10.0 | 2.0–149.0 | 0.6351 |
*
P-value for the difference between cases and controls (within lines).